by © Alessandro Melis | Dreamstime.com Switzerland’s federal government has increased the amount of money earmarked for SARS-CoV-2 vaccines by CHF 100 million, bringing the total to CHF 400 million. The announcement came as preliminary trials of a vaccine developed by Pfizer and BioNTech found it to be more than 90% effective in preventing Covid-19 in ...
Topics:
Investec considers the following as important: 3) Swiss Markets and News, 3.) Health, Coronavirus Switzerland, Covid-19 Switzerland, Editor's Choice, Featured, health, newsletter, SARS-CoV-2 Switzerland
This could be interesting, too:
Investec writes Swiss to vote on tenancy laws this weekend
Eamonn Sheridan writes CHF traders note – Two Swiss National Bank speakers due Thursday, November 21
Charles Hugh Smith writes How Do We Fix the Collapse of Quality?
Marc Chandler writes Sterling and Gilts Pressed Lower by Firmer CPI
© Alessandro Melis | Dreamstime.com
Switzerland’s federal government has increased the amount of money earmarked for SARS-CoV-2 vaccines by CHF 100 million, bringing the total to CHF 400 million.
The announcement came as preliminary trials of a vaccine developed by Pfizer and BioNTech found it to be more than 90% effective in preventing Covid-19 in participants without evidence of prior SARS-CoV-2 infection.
Switzerland had already set aside money to buy 4.5 million doses of a vaccine from Moderna and 5.3 million doses a vaccine from AstraZeneca. The additional money will allow the federal government to consider other vaccines.
Even if there is no obligation to get vaccinated, our role as the government is to ensure that we make it possible for those that do, said Alain Berset, Switzerland’s minister in charge of health.
The Pfizer and BioNTech vaccine, which is taken in two doses three weeks apart, is being tested on around 43,500 people in six countries. However, the recently published results are based on the results on only the first 94 test subjects.
The vaccine is RNA-based, which involves taking a piece of viral genetic code and using it to trigger an immune response. RNA- and DNA-based vaccines are relatively new. Some are currently used by vets on animals, however humans have so far only received them as part of clinical testing.
Pfizer and BioNTech say they will have enough safety data on their vaccine by the third week of November to take it to regulators. Any vaccine used in Switzerland would need to meet Swissmedic safety and effectiveness standards.
Some questions remain on the Pfizer/BioNTech vaccine. It is unclear how well the vaccine works on high-risk elderly people, whether it stops people spreading the virus and how long the protection might last. In addition, storing the vaccine at an ultra-cold -80 celsius presents logistical challenges.
While it is impossible to know when SARS-CoV-2 vaccines will be available, Switzerland’s Federal Office of Public Health estimates that the the first vaccinations in Switzerland will take place in the first half of 2021.
You Might Also Like
Coronavirus: no significant slowdown in new cases in Switzerland
In the seven days to 10 July 2020, the reported number of new SARS-CoV-2 infections recorded in Switzerland was 589, a similar number to the week before, when 615 new cases were recorded.
Referendum launched against SwissCovid app
A group in Switzerland has decided to launch a vote against Switzerland’s contact tracing app, an application designed to make it easier to know whether someone has been in contact with someone infected with the SARS-CoV-2 virus.
Most returning to Switzerland from Covid-19 risk countries skipping quarantine
Less than half of those returning to Switzerland from countries listed by the Swiss government as having a high risk of SARS-CoV-2 infection are complying with the quarantine rules set out in Switzerland’s Epidemic Act, according to an estimate by the NZZ newspaper.
Coronavirus: Swiss health authority adds pregnant women to risk list
After a number of recent studies that suggest pregnant women are exposed to higher risks from the SARS-CoV-2 virus, Switzerland’s Federal Office of Public Health (FOPH) adds them to the list of people vulnerable to Covid-19. The FOPH reached its recent conclusion based on discussions with the Swiss society of gynecology and obstetrics. The society sets out the findings of a number of studies in a report.
Coronavirus: could masks explain Switzerland’s sharply declining death rate?
In Switzerland, over the three months following 31 May 2020, there have been 11,306 recorded cases of Covid-19 and 91 deaths, a case fatality rate (CFR) of 0.8%. However, up to this date there were 30,862 cases and 1,920 deaths, a CFR of 6.2%. Why has Switzerland’s CFR fallen so steeply?
2500 students quarantined at Lausanne’s hotel school
Around three quarters of the students at the hotel school of Lausanne (EHL) have been placed in quarantine after a number of students tested positive for SARS-CoV-2, reported RTS.
Coronavirus: new rules from tomorrow as cases rise fast in Switzerland
On 18 October 2020, after an extraordinary meeting, Switzerland’s Federal Council announced masks would become mandatory across all of Switzerland. In addition, certain gatherings of more than 15 people are to be banned and employers are required to follow recommendations for staff to work from home.
Coronavirus: Geneva hospital calls for volunteers as numbers rise rapidly
On Sunday 25 October 2020, Geneva’s HUG hospital issued a call for volunteers as the number of Covid-19 patients rises rapidly. The hospital seeks medical, care and administrative volunteers to bolster and relieve their staff. In addition, they seek those who might have recently retired or who are on leave.
Tags: Coronavirus Switzerland,Covid-19 Switzerland,Editor's Choice,Featured,Health,newsletter,SARS-CoV-2 Switzerland